FMGE · blueprint and recall
FMGE Antiparkinsonian drugs
Candidates recalled antiparkinsonian drugs from 2 of the 19 FMGE sessions in this collection, including 2 of the 11 well-covered ones. It first appears in FMGE Aug 2020 and last in FMGE Jun 2022. 1 of its 2 recalled concepts came as a one-liner.
- Concepts in recalled topics
- 2
- unofficial
- Sessions seen in
- 2
- Well-covered sessions
- 2
- with this topic recorded
- Image-linked concepts
- 0
Recurrence in this collection
Each recalled session counts once for this topic, even if it contains several related concepts.
Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.
First seen: FMGE Aug 2020. Last seen: FMGE Jun 2022.
First and last seen refer to this recall collection only. Thin coverage limits what absence can tell you. Read the method.
Question styles and image links
Question styles in the recall
- one-liner
- 1 concepts · 50.0%
- vignette
- 1 concepts · 50.0%
Within this topic
Finer labels from the unofficial recall, grouped under Lumi's outline topic.
Subtopics represented
- Antiparkinsonian drugs
Image types recorded
No concepts recorded in this category.
Image-type percentages use all 2 concepts in this topic as the denominator. The labels describe images in recall; no images are reproduced.
Related topics in this chapter
Central Nervous System
Antiepileptics
Seen in 10 of the 19 sessions with recall; 7 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jan 2025.
Styles: one-liner (6) · vignette (2) · image + vignette (1).
Central Nervous System
Antipsychotics
Seen in 6 of the 19 sessions with recall; 4 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jan 2025.
Styles: vignette (3) · one-liner (1).
Central Nervous System
Opioids
Seen in 3 of the 19 sessions with recall; 3 of the 11 well-covered sessions.
First seen: FMGE Dec 2019. Last seen: FMGE Jul 2025.
Styles: one-liner (2).
Central Nervous System
Antidepressants
Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.
First seen: FMGE Jun 2019. Last seen: FMGE Jun 2022.
Styles: one-liner (1).
Central Nervous System
General and local anaesthetics
Seen in 2 of the 19 sessions with recall; 1 of the 11 well-covered sessions.
First seen: FMGE Dec 2011. Last seen: FMGE Dec 2018.
Styles: one-liner (2).
Central Nervous System
Sedative-hypnotics
Seen in 2 of the 19 sessions with recall; 1 of the 11 well-covered sessions.
First seen: FMGE Jun 2019. Last seen: FMGE Jul 2023.
Styles: one-liner (1).